Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Syo Nakajima"'
Autor:
Fumio Sugawara, Shinji Kamisuki, Kenji Takemoto, Koichi Watashi, Yuri Katayama, Syo Nakajima, Masashi Iwamoto, Senko Tsukuda, Shu Nishikori, Susumu Kobayashi, Takahiro Suzuki, Kouji Kuramochi
Publikováno v:
Journal of Natural Products. 79:442-446
New diazabicyclo[2.2.2]octane derivatives, peniciherquamides A-C (1-3), and a novel herqueinone derivative, neoherqueinone (5), were isolated from a fungal culture broth of Penicillium herquei. The structures of these novel compounds were determined
Autor:
Hirofumi Ohashi, Hideki Aizaki, Sulyi Kim, Koichi Watashi, Ryosuke Suzuki, Syo Nakajima, Fumio Sugawara, Naoko Ohtani, Kazane Nishioka, Shinji Kamisuki, Masayoshi Fukasawa, Takaji Wakita, Masamichi Muramatsu
Publikováno v:
The Journal of biological chemistry. 293(51)
Viruses hijack and modify host cell functions to maximize viral proliferation. Hepatitis C virus (HCV) reorganizes host cell metabolism to produce specialized membrane structures and to modify organelles such as double-membrane vesicles and enlarged
Autor:
Alan S. Perelson, Takaji Wakita, Yoshiki Koizumi, Koichi Watashi, Shingo Iwami, Yasuhito Tanaka, Hirofumi Ohashi, Syo Nakajima
With the introduction of direct-acting antivirals (DAAs), treatment against hepatitis C virus (HCV) has significantly improved. To manage and control this worldwide infectious disease better, the "best" multidrug treatment is demanded based on scient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::feef1fb63fd30ecf28e74d596f10331c
https://europepmc.org/articles/PMC5338374/
https://europepmc.org/articles/PMC5338374/
Autor:
Katyna Borroto-Esoda, Masashi Iwamoto, Syo Nakajima, Yoshikatsu Kanai, Takaji Wakita, Ann Sluder, Koichi Watashi, Masaya Sugiyama, Takuji Daito, Hiroyuki Kusuhara, Satoko Matsunaga, Yasuhito Tanaka, Masashi Mizokami, Senko Tsukuda, Akihide Ryo, Shushi Nagamori
Publikováno v:
Hepatology (Baltimore, Md.)
Hepatology
Hepatology
Chronic hepatitis B virus (HBV) infection is a major public health problem worldwide. Although nucleos(t)ide analogs inhibiting viral reverse transcriptase are clinically available as anti-HBV agents, emergence of drug-resistant viruses highlights th
Autor:
Fumio Sugawara, Kouji Kuramochi, Toshifumi Takeuchi, Masahiro Ishima, Hiroshi Murata, Syo Nakajima, Toshitaka Fujii, Susumu Kobayashi, Shinji Kamisuki, Takahiro Suzuki, Satomi Shimura, Kentaro Ikeda, Koichi Watashi, Jesus Izaguirre-Carbonell, Natsumi Himeno
Publikováno v:
Journal of the American Chemical Society. 135:18949-18956
The first total synthesis of MA026 and the identification of its candidate target protein for anti-hepatitis C virus activity are presented. MA026, a novel lipocyclodepsipeptide isolated from the fermentation broth of Pseudomonas sp. RtIB026, consist
Autor:
Mami Matsuda, Senko Tsukuda, Syo Nakajima, Fumio Sugawara, Shinji Kamisuki, Hideki Aizaki, Kenji Takemoto, Ryosuke Suzuki, Takaji Wakita, Koichi Watashi
Publikováno v:
Biochemical and Biophysical Research Communications. 440:515-520
Hepatitis C virus (HCV) is a major causative agent of hepatocellular carcinoma. Although various classes of anti-HCV agents have been under clinical development, most of these agents target RNA replication in the HCV life cycle. To achieve a more eff
Autor:
Andrew Tae-Jun Kwon, Tomohiko Takasaki, Tadaki Suzuki, Ryosuke Suzuki, Meng Ling Moi, Takanobu Kato, Shinji Kamisuki, Minetaro Arita, Hideki Aizaki, Koichi Watashi, Hideki Hasegawa, Jesus Izaguirre-Carbonell, Takaji Wakita, Harukazu Suzuki, Maiko Okada, Syo Nakajima, Michiyo Kataoka, Senko Tsukuda, Fumio Sugawara, Toshifumi Takeuchi, Hirofumi Ohashi
Cell culture systems reproducing virus replication can serve as unique models for the discovery of novel bioactive molecules. Here, using a hepatitis C virus (HCV) cell culture system, we identified neoechinulin B (NeoB), a fungus-derived compound, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e00bbd43db6eaf44e53421e17f90fda
https://europepmc.org/articles/PMC5044839/
https://europepmc.org/articles/PMC5044839/
Autor:
Takashi Fujita, Hirofumi Ohashi, Takaji Wakita, Koichi Watashi, Ann Sluder, Takuji Daito, Katyna Borroto-Esoda, Syo Nakajima
Publikováno v:
Gastroenterology. 147(2)
Background & Aims Cyclophilin inhibitors are being developed for treatment of hepatitis C virus (HCV) infection. They are believed to inhibit the HCV replication complex. We investigated whether cyclophilin inhibitors interact with interferon (IFN) s
Autor:
Yoshiki Koizumi, Takaji Wakita, Hirofumi Ohashi, Syo Nakajima, Koichi Watashi, Yasuhito Tanaka, Perelson, Alan S., Shingo Iwami
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America; 2/21/2017, Vol. 114 Issue 8, p1922-1927, 6p
Autor:
Syo Nakajima1,2, Koichi Watashi1,2,3 kwatashi@nih.go.jp., Hirofumi Ohashi1,2, Shinji Kamisuki2,4, Izaguirre-Carbonell, Jesus2, Tae-Jun Kwon, Andrew5, Harukazu Suzuki5, Michiyo Kataoka6, Senko Tsukuda1,7, Okada, Maiko8, Meng Ling Moi9,10, Toshifumi Takeuchi11,12, Arita, Minetaro1, Ryosuke Suzuki1, Hideki Aizaki1, Takanobu Kato1, Tadaki Suzuki6, Hideki Hasegawa6, Tomohiko Takasaki9, Fumio Sugawara2
Publikováno v:
Journal of Virology. Oct2016, Vol. 90 Issue 20, p9058-9074. 17p.